Role of mitochondrial translocation of telomerase in hepatocellular carcinoma cells with multidrug resistance

International Journal of Medical Sciences

Volumn 9, Issue 7, 2012, Pages 545-554

  Ling, Xianlong ^a   Wen, Lei ^a   Zhou, Yuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Mitochondria; Multidrug resistance; Telomerase; Telomere

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOCHONDRIAL DNA; TELOMERASE REVERSE TRANSCRIPTASE; VINCRISTINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL NUCLEUS; CELL PROTECTION; CELL SURVIVAL; CHEMICAL STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; DNA DAMAGE; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LIVER CELL CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MULTIDRUG RESISTANCE; OXIDATIVE STRESS; PHARMACOLOGICAL PARAMETERS; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; RESISTANCE INDEX; SIGNAL TRANSDUCTION; TELOMERE SHORTENING; TUMOR ESCAPE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE;

EID: 84866557880     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4648     Document Type: Article

References (22)

1. Pérez-Tomás R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 2006;13:1859-1876
2. Szakács G, Paterson J. Targeting multidrug resistance in cancer. Nat Rev Drug Discover 2006;5:219-234
3. Teodori E, Dei S, Martelli C, Scapecchi S, Gualtieri F. The functions and structure of ABC transporters: implications for the design of new inhib-itors of Pgp and MRP1 to control multidrug resistance (MDR). Curr Drug Targets 2006;7:893-909
4. Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, et al. hTERT reverse transcriptase delays aging in can-cer-resistant mice. Cell 2008;135:609-622
5. Saretzki G. hTERT, mitochondria and oxidative stress. Exp Geronto 2009;44:485-492
6. Kuranaga N, Shinomiya N, Mochizuki H. Longterm cultivation of colo-rectal carcinoma cells with anticancer drugs induces drug resistance and telomere elongation: An in vitro study. BMC Cancer 2001; 1:10-19
7. Li S, Crothers J, Haqq CM. Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of hTERT RNA. J Biol Chem 2005; 280:23709-23717
8. Bagheri S, Nosrati M, Li S, Fong S, Torabian S, Rangel J, et al. Genes and pathways downstream of hTERT in melanoma metastasis. Proc Natl Acad Sci USA 2006; 103:11306-11311
9. Ahmed S, Passos JF, Birket MJ, Beckmann T, Brings S, Peters H, et al. hTERT does not counteract telomere shortening but protects mitochon-drial function under oxidative stress. J Cell Sci 2008;17:1046-1053
10. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W, et al. TERT promotes epithelial proliferation through transcriptional control of a Myc-and Wnt-related developmental program. PLoS Genet 2008; 4:e10
11. Haendeler J, Dröse S, Büchner N, Jakob S, Altschmied J, Goy C, et al. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 2009; 29:929-935
12. Zhou Y, Ling XL, Li SW, Li XQ, Yan B. Establishment of a human hepa-toma multidrug resistant cell line in vitro. World J Gastroenterol 2010; 16:2291-2297
13. Chen J, Kadlubar FF, Chen JZ. DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA dam-age and repair. Nucleic Acids Res 2007; 35:1377-1388
14. Passos J, Saretzki G, Ahmed S, Nelson G, Richter T, Peters H, et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 2007; 5:e110
15. Santos JH, Meyer JN, Mandavilli BS, Van Houten B. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods Mol Biol 2006; 314:183-199
16. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30:e47
17. Liu FS. Mechanisms of chemotherapeutic drug resistance in cancer therapy-a quick review. Taiwan J Obstet Gynecol 2009; 48:239-244
18. Moitra K, Lou H, Dean M. Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development. Clin Pharm Therap 2011; 89:491-502
19. Nason-Burchenal K, Maerz W, Allopenna J, Allopenna J, Martin P, Moore MA, et al. Common defects of different retinoic acid resistant promye-locytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Differentiation 1997; 61:321-331
20. de Magalhães JP, Chainiaux F, Remacle J, Toussaint O. Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin fibroblasts. FEBS Lett 2002; 523:157-162
21. Gorbunova V, Seluanov A, Pereira-Smith OM. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in nor-mal human fibroblasts but protects the cells from stress-induced apop-tosis and necrosis. Biol Chem 2002; 277:38540-38549
22. Sedensky MM, Morgan PG. Mitochondrial respiration and reactive oxygen species in mitochondrial aging mutants. Exp Gerontol 2006; 41:237-245